Boston Scientific has launched the Farapulse Pulsed Field Ablation system across India, Indonesia, Thailand and Vietnam, bringing a non-thermal cardiac ablation technology to markets where AF burden is rapidly increasing.
Boston Scientific has officially launched the Farapulse Pulsed Field Ablation (PFA) system across India, Indonesia, Thailand and Vietnam, following regulatory clearances from CDSCO and local health authorities in Southeast Asia.
The Farapulse system uses non-thermal electrical energy to selectively destroy heart tissue causing atrial fibrillation, offering a fundamentally safer profile than traditional thermal ablation methods that risk damage to adjacent structures.
Clinical Advantages
- Procedure time: 60-90 minutes vs. 3-4 hours for RF ablation
- Cardiac tamponade rate: 0.1% vs. 1.5% for RF
- Pulmonary vein reconnection at 12 months: 15% vs. 40%
- Day-case procedure possible in 85% of patients
The system will initially be available at 12 high-volume cardiac centres in India including AIIMS New Delhi, Apollo Chennai and Kokilaben Ambani Hospital Mumbai. Training programmes begin in April 2026.
Atrial fibrillation affects an estimated 8 million people in India alone, yet catheter ablation penetration remains below 2% of eligible patients due to access and cost barriers.